Sativa Wellness Group Announces Record Week
VANCOUVER, BC, December 6, 2021 / Accesswire / Sativa Wellness Group Inc. (CSE: SWEL) (“Sativa Wellness” or the “Company”) is pleased to announce that last week was the Company’s best week to date for bookings, with several days exceeding previous records. This meant the company exceeded £13.8m revenue in the eleven months to the end of November.
There are now over 140 clinics in the Goodbody network, including Superdrug supporting clinics. Goodbody clinics will continue to roll out blood testing while responding to the government’s latest guidance for the new COVID-19 Omicron variant. All travellers will now have to have a PCR test two days after they return to the UK and our clinics are available to book online at Private Covid Testing England & Wales (goodbodyclinic.com) - https://www.goodbodyclinic.com/ ).
Geremy Thomas, Executive Chairman, said; “We are pleased to be able to support the return of PCR testing as the gold standard of COVID detection and trust that this in combination with vaccinations will control this new variant of the virus. We are delighted that we have now achieved over £13m revenue while meeting this need.”
The Directors of the Company accept responsibility for the contents of this announcement.
On behalf of the Board of Directors,
Marc Howells
Chief Executive Officer
Sativa Wellness Group Inc.
+44 (0) 20 7971 1255
Anne Tew
Chief Financial Officer
Sativa Wellness Group Inc.
+44 (0) 20 7971 1255
Neither the Canadian Securities Exchange nor its Market Regulator (as defined in the policies of the Canadian Securities Exchange) accept responsibility for the adequacy or accuracy of this release. This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Sativa’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes" "plan is" or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur", "will be achieved" or "shortly". The forward-looking information and forward-looking statements contained herein include,but are not limited to that PCR testing in combination with vaccinations will control this new variant of the virus.
Although Sativa believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this news release are made as of the date of this press release, and include but are not limited to that PCR testing in combination with vaccinations will control this new variant of the virus.
Sativa does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.
